Exiting the EU: our work to ensure the best deal for cancer research and patients

Brexit & the EU

Get in touch

To request a meeting or further information about our work please contact the Public Affairs team.

Email us

Following the British public’s decision to leave the European Union, we’ll be working hard to help inform negotiations, ensuring cancer patients in the UK and across the EU are prioritised in Brexit talks.

Health and science are global. And collaboration between the UK and countries in Europe and beyond enables the discoveries that benefit patients everywhere. So we’ll be following progress on the UK’s new relationship with the EU closely and seeking to input our expertise on the issues we care most about.

As the largest independent funder of research in Europe we remain committed to collaborating across borders within Europe, and globally, to beat cancer sooner.

Scientists have greater impact when they collaborate internationally.

A report funded by eight leading UK medical research funders and charities identifies some of the main ways in which UK research contributes to medical progress. It highlights the benefit this has delivered for EU science, and ultimately how this has improved the health of patients across the EU.

Related documents

Cancer Research UK response to MHRA consultation on EU exit no-deal proposals (November 2018)

Cancer Research UK’s response to the MHRA No Deal consultation (November 2018)

Impact of a no deal Brexit - Cancer Research UK submission to Health and Social Care Committee inquiry (October 2018)

CRUK Policy Position: Summary of Brexit priorities (September 2018)

Cancer Research UK briefing - European regulatory system for medicines (September 2018)

Cancer Research UK’s policy statement on clinical trials as the UK exits the EU (August 2018)

The Future of Clinical Trials After Brexit report (August 2018)

The Future of Clinical Trials After Brexit slide deck (August 2018)

Response to the House of Commons Science and Technology Committee (June 2018)

Cancer charity joint letter: Priorities for second phase Brexit negotiations

CRUK policy position: Clinical Trials Regulation

CRUK Policy position: Drug licensing

CRUK Policy position: Researcher mobility (May 2018)

Cancer Research UK response to Science and Technology inquiry: Brexit science and innovation summit (February 2018)

Cancer Research UK response to Wellcome-Royal Society Future Partnership Project (January 2018)

Migration Advisory Committee call for evidence: the social and economic impact of international students— Cancer Research UK response (January 2018)

Cancer Research UK response to the Scottish Parliament Health and Sport Committee inquiry: ‘Impact of leaving the European Union on health and social care in Scotland’ (January 2018)

Cancer Research UK response to Migration Advisory Committee call for evidence: EEA-workers in the UK labour market (October 2017)

Home Affairs Committee inquiry: Developing a consensus on an effective immigration policy Cancer Research UK’s response (January 2017)

Campaign for us

Rate this page:

Currently rated: 3.1 out of 5 based on 11 votes
Thank you!
We've recently made some changes to the site, tell us what you think